Northern Trust Corp Immuno Precise Antibodies Ltd. Transaction History
Northern Trust Corp
- $600 Billion
- Q3 2024
A detailed history of Northern Trust Corp transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Northern Trust Corp holds 50,730 shares of IPA stock, worth $20,292. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,730
Previous 50,730
-0.0%
Holding current value
$20,292
Previous $51,000
37.25%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IPA
# of Institutions
19Shares Held
1.9MCall Options Held
0Put Options Held
0-
Ingalls & Snyder LLC New York, NY1.56MShares$623,5560.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny60.3KShares$24,1200.0% of portfolio
-
Bank Of Montreal Toronto, A657.8KShares$23,1220.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$16,4800.0% of portfolio
-
Gradient Capital Advisors, LLC26.8KShares$10,7230.01% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $9.93M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...